Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

ClinicalTrials.gov ID: NCT01093118

Public ClinicalTrials.gov record NCT01093118. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TMI-358 in the Treatment of Distal Subungual Onychomycosis of the Toenail

Study identification

NCT ID
NCT01093118
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Talima Therapeutics, Inc.
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • TMI-358 Drug
  • MMI-467 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2009
Primary completion
Mar 31, 2011
Completion
Not listed
Last update posted
Jan 16, 2011

Started 2009

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Radiant Research, Inc. Tucson Arizona 85710
Therapeutics Clinical Research San Diego California 92123
International Dermatology Research Center Miami Florida 33144
Radiant Research, Inc. Cincinnati Ohio 45249
Oregon Medical Research Center Portland Oregon 97223
J&S Studies, Inc. College Station Texas 77845
Dermatology Research Center Salt Lake City Utah 84124

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01093118, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2011 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01093118 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →